Insights On Outsourced Drug Development

  1. What Is The FusionOptics Technology? 1/8/2024

    Learn about stereo microscopes that combine high resolution and depth of field to provide a superior 3D perception of samples.

  2. Softgel Formulation: Addressing Stability, Shelf-Life, And Bioavailability 5/16/2024

    A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.

  3. Characterize Lentiviral Vector Quality Attributes Using CE Platform Technology 8/14/2023

    Review this outline of a platform-based approach using capillary electrophoresis (CE) to mitigate the technical difficulties in characterizing LVVs for the assessment of multiple quality attributes.

  4. Rapid And Simple Aggregate Removal Of mAbs Using Competitive Binding On CEX 3/28/2025

    To ensure the safety, efficacy, and stability of monoclonal antibody therapies, it is crucial to understand the factors driving aggregation and implement effective strategies to mitigate its impact.

  5. Mitigating Early Development Risks 9/11/2024

    Discover how the efficient screening of biologic candidates accelerates the discovery process, reduces costs, and improves the likelihood of commercializing safe and effective drugs.

  6. How Recent Trends Impact Bringing Your Molecule To Market 7/9/2024

    With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.

  7. Is Lipinski's Rule Of Five Still Relevant In Drug Development? 11/13/2024

    Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.

  8. Advancements In GLP-1 Analog Formulation: Overcoming Challenges 2/3/2025

    Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.

  9. How A Privately Owned CDMO Is Transforming Client Expectations 5/16/2024

    Finding a partner with flexible services and a strong emphasis on building long-term client relationships can help ensure success for your pharmaceutical product.

  10. N-Linked Glycan Analysis Of NISTmAb 8/11/2023

    With the right glycan analysis kit, you can achieve a 1-minute-per-sample analysis rate, along with streamlined and high-throughput glycan analysis assay for all phases of biopharmaceutical development.